Pharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age With ADHD

NCT02470234 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention-Deficit/Hyperactivity Disorder

Interventions

DRUG: Methylphenidate HCl ER Capsules, 10 mg
DRUG: Methylphenidate HCl ER Capsules, 15 mg
DRUG: Methylphenidate HCl ER Capsules, 20 mg

Sponsor

Rhodes Pharmaceuticals, L.P.